Astrana Health (NASDAQ:ASTH) Trading Up 5.3% – Still a Buy?

Shares of Astrana Health, Inc. (NASDAQ:ASTH) rose 5.3% on Monday . The company traded as high as $27.19 and last traded at $26.74. Approximately 82,603 shares were traded during mid-day trading, a decline of 66% from the average daily volume of 240,060 shares. The stock had previously closed at $25.38.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Stifel Nicolaus decreased their price target on Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research note on Thursday, February 20th. Robert W. Baird decreased their target price on Astrana Health from $86.00 to $50.00 and set an “outperform” rating on the stock in a research report on Monday. Truist Financial lowered their target price on Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a research note on Monday, January 13th. Finally, Macquarie upgraded shares of Astrana Health to a “hold” rating in a research note on Monday, December 16th. Two research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $58.40.

Astrana Health Stock Up 4.3 %

The firm has a 50-day simple moving average of $34.84 and a 200 day simple moving average of $44.46. The stock has a market capitalization of $1.49 billion, a P/E ratio of 20.37, a P/E/G ratio of 1.37 and a beta of 1.20. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The business had revenue of $665.21 million during the quarter, compared to the consensus estimate of $617.24 million. On average, equities research analysts forecast that Astrana Health, Inc. will post 1.15 EPS for the current year.

Hedge Funds Weigh In On Astrana Health

Hedge funds have recently modified their holdings of the business. Nisa Investment Advisors LLC bought a new position in Astrana Health during the 3rd quarter worth $35,000. Pilgrim Partners Asia Pte Ltd bought a new position in shares of Astrana Health during the fourth quarter worth about $40,000. Quarry LP lifted its stake in shares of Astrana Health by 35.5% in the fourth quarter. Quarry LP now owns 1,799 shares of the company’s stock worth $57,000 after acquiring an additional 471 shares during the period. KBC Group NV acquired a new position in shares of Astrana Health in the third quarter worth approximately $70,000. Finally, Quest Partners LLC bought a new stake in Astrana Health in the third quarter valued at approximately $133,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.